BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci. 2010;55:3124-3131. [PMID: 20668939 DOI: 10.1007/s10620-010-1351-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Bornschein J, Nielitz J, Drozdov I, Selgrad M, Wex T, Jechorek D, Link A, Vieth M, Malfertheiner P. Expression of aurora kinase A correlates with the Wnt-modulator RACGAP1 in gastric cancer. Cancer Med 2016;5:516-26. [PMID: 26778597 DOI: 10.1002/cam4.610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
2 Imamura Y, Watanabe M, Oki E, Morita M, Baba H. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study. Ann Gastroenterol Surg 2021;5:46-59. [PMID: 33532680 DOI: 10.1002/ags3.12406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lindblad A, Kaucher S, Jaehn P, Kajüter H, Holleczek B, Lissner L, Becher H, Winkler V. The Incidence of Intestinal Gastric Cancer among Resettlers in Germany-Do Resettlers Remain at an Elevated Risk in Comparison to the General Population? Int J Environ Res Public Health 2020;17:E9215. [PMID: 33317154 DOI: 10.3390/ijerph17249215] [Reference Citation Analysis]
4 Bornschein J, Dingwerth A, Selgrad M, Venerito M, Stuebs P, Frauenschlaeger K, Achilleos A, Roessner A, Malfertheiner P. Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions. Eur J Gastroenterol Hepatol 2015;27:492-500. [PMID: 25822856 DOI: 10.1097/MEG.0000000000000299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhu Y, Jiang H, Chen Z, Lu B, Li J, Peng Y, Shen X. The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis. Onco Targets Ther 2018;11:2497-507. [PMID: 29765229 DOI: 10.2147/OTT.S161925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hayakawa Y, Sethi N, Sepulveda AR, Bass AJ, Wang TC. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev Cancer. 2016;16:305-318. [PMID: 27112208 DOI: 10.1038/nrc.2016.24] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 13.6] [Reference Citation Analysis]
7 Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A. Inflammation and Barrett's carcinogenesis. Pathol Res Pract. 2012;208:269-280. [PMID: 22541897 DOI: 10.1016/j.prp.2012.03.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
8 Lv L, Liang X, Wu D, Wang F, Zhang Y, Cang H, Deng X, Li M. Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer. J Cancer 2021;12:2385-94. [PMID: 33758614 DOI: 10.7150/jca.51433] [Reference Citation Analysis]
9 Ren Z, Rajani C, Jia W. The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers. Cancers (Basel) 2021;13:720. [PMID: 33578739 DOI: 10.3390/cancers13040720] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Bornschein J, Wernisch L, Secrier M, Miremadi A, Perner J, MacRae S, O'Donovan M, Newton R, Menon S, Bower L, Eldridge MD, Devonshire G, Cheah C, Turkington R, Hardwick RH, Selgrad M, Venerito M, Malfertheiner P, Fitzgerald RC; OCCAMS Consortium. Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction. Int J Cancer 2019;145:3389-401. [PMID: 31050820 DOI: 10.1002/ijc.32384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
11 Azari FS, Roses RE. Management of Early Stage Gastric and Gastroesophageal Junction Malignancies. Surg Clin North Am. 2019;99:439-456. [PMID: 31047034 DOI: 10.1016/j.suc.2019.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yin X, Lin H, Lin L, Miao L, He J, Zhuo Z. LncRNAs and CircRNAs in cancer. MedComm 2022;3. [DOI: 10.1002/mco2.141] [Reference Citation Analysis]
14 Shrivastava MS, Hussain Z, Giricz O, Shenoy N, Polineni R, Maitra A, Verma A. Targeting chemokine pathways in esophageal adenocarcinoma. Cell Cycle 2014;13:3320-7. [PMID: 25485576 DOI: 10.4161/15384101.2014.968426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
15 Venerito M, Goni E, Malfertheiner P. Helicobacter pylori screening: options and challenges. Expert Rev Gastroenterol Hepatol 2016;10:497-503. [PMID: 26619972 DOI: 10.1586/17474124.2016.1126507] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
16 Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort. Cancer Med 2018;7:5145-54. [PMID: 30239168 DOI: 10.1002/cam4.1763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Zhang T, Cao HL, Luo SJ, Zheng DL, Chen YN. Construction of a gastric cancer cell line with stably silenced expression of CD14. Shijie Huaren Xiaohua Zazhi 2014; 22(22): 3194-3200 [DOI: 10.11569/wcjd.v22.i22.3194] [Reference Citation Analysis]
18 Pennathur A, Godfrey TE, Luketich JD. The Molecular Biologic Basis of Esophageal and Gastric Cancers. Surg Clin North Am 2019;99:403-18. [PMID: 31047032 DOI: 10.1016/j.suc.2019.02.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Xu C, Liu Z, Xiao J. Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease. Int J Mol Sci 2021;22:12403. [PMID: 34830285 DOI: 10.3390/ijms222212403] [Reference Citation Analysis]
20 Roesler BM, Costa SC, Zeitune JM. Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer. ISRN Gastroenterol. 2012;2012:935410. [PMID: 22778979 DOI: 10.5402/2012/935410] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
21 Ouyang J, Xie Z, Lei X, Tang G, Gan R, Yang X. Clinical crosstalk between microRNAs and gastric cancer (Review). Int J Oncol 2021;58:7. [PMID: 33649806 DOI: 10.3892/ijo.2021.5187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rehkaemper J, Korenkov M, Quaas A, Rueschoff J, Pamuk A, Zander T, Hillmer AM, Buettner R, Hoelscher AH, Bruns CJ, Loeser H, Alakus H, Schoemig-Markiefka B. Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas. BMC Cancer 2020;20:587. [PMID: 32571252 DOI: 10.1186/s12885-020-06996-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Castaño-Rodríguez N, Kaakoush NO, Mitchell HM. Pattern-recognition receptors and gastric cancer. Front Immunol 2014;5:336. [PMID: 25101079 DOI: 10.3389/fimmu.2014.00336] [Cited by in Crossref: 17] [Cited by in F6Publishing: 47] [Article Influence: 2.1] [Reference Citation Analysis]
24 Ahn HJ, Lee DS. Helicobacter pylori in gastric carcinogenesis. World J Gastrointest Oncol 2015; 7(12): 455-465 [PMID: 26690981 DOI: 10.4251/wjgo.v7.i12.455] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
25 Li W, Cui X, Qi A, Yan L, Wang T, Li B. miR-183-5p acts as a potential prognostic biomarker in gastric cancer and regulates cell functions by modulating EEF2. Pathol Res Pract 2019;215:152636. [PMID: 31558304 DOI: 10.1016/j.prp.2019.152636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Gao S, Brown J, Wang H, Feng X. The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer. Arch Immunol Ther Exp (Warsz) 2014;62:131-44. [PMID: 24276788 DOI: 10.1007/s00005-013-0263-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
27 Lazăr DC, Tăban S, Cornianu M, Faur A, Goldiş A. New advances in targeted gastric cancer treatment. World J Gastroenterol 2016; 22(30): 6776-6799 [PMID: 27570417 DOI: 10.3748/wjg.v22.i30.6776] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
28 Chheda PR, Cooling GT, Dean SF, Propp J, Hobbs KF, Spies MA. Decrypting a cryptic allosteric pocket in H. pylori glutamate racemase. Commun Chem 2021;4. [DOI: 10.1038/s42004-021-00605-z] [Reference Citation Analysis]
29 Coelho LG, Maguinilk I, Zaterka S, Parente JM, do Carmo Friche Passos M, Moraes-Filho JP. 3rd Brazilian Consensus on Helicobacter pylori. Arq Gastroenterol. 2013;50. [PMID: 23748591 DOI: 10.1590/s0004-28032013005000001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
30 Malfertheiner P, Venerito M, Selgrad M. Helicobacter pylori infection: selected aspects in clinical management. Curr Opin Gastroenterol. 2013;29:669-675. [PMID: 24100726 DOI: 10.1097/mog.0b013e328365d443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
31 Hardikar S, Onstad L, Song X, Wilson AM, Montine TJ, Kratz M, Anderson GL, Blount PL, Reid BJ, White E, Vaughan TL. Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort. Cancer Epidemiol Biomarkers Prev 2014;23:2393-403. [PMID: 25106775 DOI: 10.1158/1055-9965.EPI-14-0384] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
32 Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol. 2012;12:10. [PMID: 22289789 DOI: 10.1186/1471-230x-12-10] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
33 Jing Y, Xu F, Liang W, Liu J, Zhang L. Role of regulatory B cells in gastric cancer: Latest evidence and therapeutics strategies. Int Immunopharmacol 2021;96:107581. [PMID: 33812259 DOI: 10.1016/j.intimp.2021.107581] [Reference Citation Analysis]
34 Peng Y, Wang L, Wu L, Zhang L, Nie G, Guo M. Methylation of SLFN11 promotes gastric cancer growth and increases gastric cancer cell resistance to cisplatin. J Cancer 2019;10:6124-34. [PMID: 31762822 DOI: 10.7150/jca.32511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
35 Coelho LGV, Marinho JR, Genta R, Ribeiro LT, Passos MDCF, Zaterka S, Assumpção PP, Barbosa AJA, Barbuti R, Braga LL, Breyer H, Carvalhaes A, Chinzon D, Cury M, Domingues G, Jorge JL, Maguilnik I, Marinho FP, Moraes-filho JPD, Parente JML, Paula-e-silva CMD, Pedrazzoli-júnior J, Ramos AFP, Seidler H, Spinelli JN, Zir JV. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arq Gastroenterol 2018;55:97-121. [DOI: 10.1590/s0004-2803.201800000-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
36 Sterea AM, Egom EE, El Hiani Y. TRP channels in gastric cancer: New hopes and clinical perspectives. Cell Calcium 2019;82:102053. [PMID: 31279156 DOI: 10.1016/j.ceca.2019.06.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Yu F, Tian T, Deng B, Wang T, Qi Q, Zhu M, Yan C, Ding H, Wang J, Dai J, Ma H, Ding Y, Jin G. Multi-marker analysis of genomic annotation on gastric cancer GWAS data from Chinese populations. Gastric Cancer 2019;22:60-8. [PMID: 29859005 DOI: 10.1007/s10120-018-0841-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Alvarado-Cabrero I, Gil-Hernández S, Ruelas-Perea A, Villaverde-Rodríguez D, Montes-Ochoa JR, Medrano-Guzmán R. [Immunohistochemical assessment of HER2 expression in gastric cancer. A clinicopathologic study of 93 cases]. Cir Cir 2017;85:504-9. [PMID: 28069112 DOI: 10.1016/j.circir.2016.11.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
39 Cai WY, Lin LY, Wang L, Yang L, Ye GD, Zeng Q, Cheng J, Xie YY, Chen ML, Luo QC. Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice. Cell Commun Signal 2019;17:72. [PMID: 31288844 DOI: 10.1186/s12964-019-0387-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
40 Bornschein J, Quante M, Jansen M. The complexity of cancer origins at the gastro-oesophageal junction. Best Pract Res Clin Gastroenterol 2021;50-51:101729. [PMID: 33975686 DOI: 10.1016/j.bpg.2021.101729] [Reference Citation Analysis]
41 Wang Y, Xu L, Ai D. A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis. Genes (Basel) 2021;12:854. [PMID: 34199440 DOI: 10.3390/genes12060854] [Reference Citation Analysis]
42 Bakhti SZ, Latifi-Navid S, Zahri S, Bakhti FS, Hajavi N, Yazdanbod A. Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran. Cancer Biomark. 2017;21:235-246. [PMID: 29036792 DOI: 10.3233/cbm-170701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
43 Hu Y, Yu K, Wang G, Zhang D, Shi C, Ding Y, Hong D, Zhang D, He H, Sun L, Zheng J, Sun S, Qian F. Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell. Biochemical Pharmacology 2018;150:280-92. [DOI: 10.1016/j.bcp.2018.02.023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
44 Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6-30. [PMID: 27707777 DOI: 10.1136/gutjnl-2016-312288] [Cited by in Crossref: 1166] [Cited by in F6Publishing: 992] [Article Influence: 194.3] [Reference Citation Analysis]
45 Miao YD, Mu LJ, Mi DH. Metabolism-associated genes in occurrence and development of gastrointestinal cancer: Latest progress and future prospect. World J Gastrointest Oncol 2021; 13(8): 758-771 [PMID: 34457185 DOI: 10.4251/wjgo.v13.i8.758] [Reference Citation Analysis]
46 Li T, Chen X, Gu M, Deng A, Qian C. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis. Clin Epigenetics 2020;12:161. [PMID: 33115518 DOI: 10.1186/s13148-020-00940-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bornschein J, Tóth K, Selgrad M, Kuester D, Wex T, Molnár B, Tulassay Z, Malfertheiner P. Dysregulation of CDX1, CDX2 and SOX2 in patients with gastric cancer also affects the non-malignant mucosa. J Clin Pathol 2013;66:819-22. [DOI: 10.1136/jclinpath-2013-201448] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
48 Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388:2654-2664. [PMID: 27156933 DOI: 10.1016/s0140-6736(16)30354-3] [Cited by in Crossref: 856] [Cited by in F6Publishing: 627] [Article Influence: 142.7] [Reference Citation Analysis]
49 Nogueira C, Mota M, Gradiz R, Cipriano MA, Caramelo F, Cruz H, Alarcão A, E Sousa FC, Oliveira F, Martinho F, Pereira JM, Figueiredo P, Leitão M. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Portugal. Infect Agent Cancer 2017;12:41. [PMID: 28814970 DOI: 10.1186/s13027-017-0151-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
50 Selgrad M, Bornschein J, Weigt J, Malfertheiner P. Molekulare Grundlagen und Pathomechanismen des Karzinoms am ösophagogastralen Übergang. Viszeralmedizin 2012;28:96-102. [DOI: 10.1159/000338182] [Reference Citation Analysis]
51 Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Juozaityte E, Kiudelis G, Jonaitis L, Malfertheiner P. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Med Genet. 2011;12:112. [PMID: 21864388 DOI: 10.1186/1471-2350-12-112] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
52 Bornschein J, Rokkas T, Selgrad M, Malfertheiner P. Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter. 2011;16 Suppl 1:45-52. [PMID: 21896085 DOI: 10.1111/j.1523-5378.2011.00880.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
53 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]